Volume 3, Issue 1 (2007) | American Journal of Immunology

HIV-1-Specific CTL Recognizing a Scarce Epitope Are Not Suppressed by HIV-1 Protease Inhibitors

Otto O. Yang — 2007-06-30

American Journal of Immunology, Published online: 30 June 2007; doi:10.3844/ajisp.2007.1.3

HIV-1-protease inhibitors have received growing attention as agents that can affect proteases in human proteasomes, with potentially deleterious effects for HIV-1-specific cellular immunity. Studying ...

Protection against Lipopolysaccharide-induced Death by An Anti-Interleukin-6 Monoclonal Antibody

Bailin Liang — 2007-06-30

American Journal of Immunology, Published online: 30 June 2007; doi:10.3844/ajisp.2007.4.9

Septicemia is frequently associated with serious complications and high mortality despite recent advances in treatment with antibacterial agents. Infectious organisms or their soluble products initiat...

The Pathology of Alzheimer Disease Elicits an In Vivo Immunological Response

David J. Bonda — 2007-06-30

American Journal of Immunology, Published online: 30 June 2007; doi:10.3844/ajisp.2007.10.14

The mechanism(s) responsible for the loss of neurons that characterizes Alzheimer disease is incompletely understood. Nonetheless, there is considerable evidence suggestive of immune abnormalities cou...

Expression of Toll-like Receptors (TLRs) and Nucleotide-binding Oligomerization Domain (NODs) in murine peritoneal macrophages on in vitro treatment with Thymosin Î± 1

Shikha Tarang — 2007-06-30

American Journal of Immunology, Published online: 30 June 2007; doi:10.3844/ajisp.2007.15.24

Thymosin α 1 (Tα1) treatment of murine peritoneal macrophages in vitro induces the expression of TLRs and Nod2 proteins. Enhanced expressions of TLR2, -4, -5, -6, -7, -8, -9 and Nod2 were observed b...